NICE removes β blockers as first line treatment for hypertensionBMJ 2006; 333 doi: https://doi.org/10.1136/bmj.333.7557.8-a (Published 29 June 2006) Cite this as: BMJ 2006;333:8
- Susan Mayor
β blockers are no longer recommended for the first line or second line treatment of hypertension, says an updated guideline for England and Wales.
The guideline recommends that for hypertensive patients aged 55 or older or for black patients of any age the first choice for initial treatment should be either a calcium channel blocker or a thiazide-type diuretic. Black patients are considered to be those of African or Caribbean descent, not people of Asian descent or mixed race people. For patients under the age of 55 an angiotensin …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial